Canada Life’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96K | Hold |
5,987
| – | – | ﹤0.01% | 1770 |
|
|
2025
Q1 | $102K | Sell |
5,987
-8,289
| -58% | -$141K | ﹤0.01% | 1777 |
|
|
2024
Q4 | $353K | Buy |
14,276
+8,289
| +138% | +$205K | ﹤0.01% | 1691 |
|
|
2024
Q3 | $171K | Sell |
5,987
-9,416
| -61% | -$269K | ﹤0.01% | 1793 |
|
|
2024
Q2 | $406K | Buy |
15,403
+3,072
| +25% | +$81K | ﹤0.01% | 1718 |
|
|
2024
Q1 | $398K | Buy |
12,331
+6,344
| +106% | +$205K | ﹤0.01% | 1733 |
|
|
2023
Q4 | $251K | Buy |
5,987
+845
| +16% | +$35.4K | ﹤0.01% | 1802 |
|
|
2023
Q3 | $197K | Buy |
5,142
+2,782
| +118% | +$107K | ﹤0.01% | 1863 |
|
|
2023
Q2 | $45K | Hold |
2,360
| – | – | ﹤0.01% | 2012 |
|
|
2023
Q1 | $37K | Hold |
2,360
| – | – | ﹤0.01% | 2112 |
|
|
2022
Q4 | $42K | Hold |
2,360
| – | – | ﹤0.01% | 2106 |
|
|
2022
Q3 | $13K | Hold |
2,360
| – | – | ﹤0.01% | 2311 |
|
|
2022
Q2 | $9K | Hold |
2,360
| – | – | ﹤0.01% | 2373 |
|
|
2022
Q1 | $14K | Hold |
2,360
| – | – | ﹤0.01% | 2401 |
|
|
2021
Q4 | $20K | Hold |
2,360
| – | – | ﹤0.01% | 2379 |
|
|
2021
Q3 | $21K | Hold |
2,360
| – | – | ﹤0.01% | 2426 |
|
|
2021
Q2 | $25K | Hold |
2,360
| – | – | ﹤0.01% | 2439 |
|
|
2021
Q1 | $38K | Buy |
2,360
+560
| +31% | +$9.02K | ﹤0.01% | 2378 |
|
|
2020
Q4 | $83K | Hold |
1,800
| – | – | ﹤0.01% | 2153 |
|
|
2020
Q3 | $63K | Hold |
1,800
| – | – | ﹤0.01% | 2130 |
|
|
2020
Q2 | $43K | Buy |
+1,800
| New | +$43K | ﹤0.01% | 2262 |
|